PFBT
ACUR

Parkside Financial Bank & Trust’s Acura Pharmaceuticals ACUR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20
Closed – – 1162
2015
Q3 		$0 Buy
+20
New +$68 ﹤0.01% 1117

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkside Financial Bank & Trust's ACUR Position: Q4 2015 in Review

Parkside Financial Bank & Trust sold out of Acura Pharmaceuticals (ACUR) in Q4 2015, closing a stake of 20 shares.

Parkside Financial Bank & Trust first reported a position in ACUR in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 22 funds tracked by Wall St. Rank hold ACUR as of Q4 2015.

  • Parkside Financial Bank & Trust reported no remaining Acura Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 20 Acura Pharmaceuticals shares in Q4 2015.
  • Parkside Financial Bank & Trust first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Acura Pharmaceuticals position peaked at $0 in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q4 2015.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2015, filed 2 Feb 2016.